Page last updated: 2024-08-26

eudragit-e and hydrogen

eudragit-e has been researched along with hydrogen in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goyanes, A; Martínez-Pacheco, R; Souto, C1
He, D; Liao, H; Liu, G; Tan, Q; Wang, H; Wu, J; Yin, H; Zhang, J; Zhang, L1
Ida, Y; Kadota, K; Kikuchi, J; Tozuka, Y; Ueda, H; Wakabayashi, S1
Hoon Jeong, S; Park, ES; Park, SJ; Seo, HJ; Thapa, P1

Trials

1 trial(s) available for eudragit-e and hydrogen

ArticleYear
Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation.
    International journal of pharmaceutics, 2018, Oct-05, Volume: 549, Issue:1-2

    Topics: Administration, Oral; Adult; Animals; Anticholesteremic Agents; Biological Availability; Cellulose; Cholesterol Ester Transfer Proteins; Double-Blind Method; Drug Carriers; Drug Compounding; Drug Development; Excipients; Female; Humans; Hydrocarbons, Fluorinated; Macaca mulatta; Male; Mannitol; Middle Aged; Models, Biological; Oxazoles; Permeability; Poloxamer; Polymethacrylic Acids; Proof of Concept Study; Solubility; Tablets; Young Adult

2018

Other Studies

3 other study(ies) available for eudragit-e and hydrogen

ArticleYear
Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 79, Issue:3

    Topics: Cellulose; Compressive Strength; Drug Compounding; Excipients; Hydrochlorothiazide; Methacrylates; Methylmethacrylates; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Solubility; Spectrophotometry, Infrared; Surface Properties; X-Ray Diffraction

2011
Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
    Drug development and industrial pharmacy, 2013, Volume: 39, Issue:9

    Topics: Animals; Cellulose; Chemical Phenomena; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Excipients; Female; Flavoring Agents; Humans; Kinetics; Male; Models, Chemical; Polymethacrylic Acids; Povidone; Pyridostigmine Bromide; Rabbits; Random Allocation; Saliva; Solubility; Tablets; Taste; Therapeutic Equivalency

2013
Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
    Molecular pharmaceutics, 2015, Apr-06, Volume: 12, Issue:4

    Topics: Amino Acids; Calorimetry, Differential Scanning; Carboxylic Acids; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Esters; Glass; Hot Temperature; Hydrogen; Hydrogen Bonding; Ions; Magnetic Resonance Spectroscopy; Methylmethacrylates; Naproxen; Plasticizers; Polymers; Powders; Solubility; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Temperature; Thermodynamics; Thermogravimetry; Transition Temperature; X-Ray Diffraction

2015